https://stock.noler.com/us/stock/keenova-therapeutics-plc https://stock.noler.com/us/stock/keenova-therapeutics-plc/accounts-payable https://stock.noler.com/us/stock/keenova-therapeutics-plc/accounts-receivable https://stock.noler.com/us/stock/keenova-therapeutics-plc/accretion-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrual-at-carrying-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrual-for-environmental-loss-contingencies https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrual-provision https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrued-environmental-loss-contingencies-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrued-environmental-loss-contingencies-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrued-income-taxes https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrued-income-taxes-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrued-income-taxes-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/accrued-royalties-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/accumulated-depreciation https://stock.noler.com/us/stock/keenova-therapeutics-plc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/keenova-therapeutics-plc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/keenova-therapeutics-plc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/keenova-therapeutics-plc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/acquisition-integration-related-costs https://stock.noler.com/us/stock/keenova-therapeutics-plc/acquisitions https://stock.noler.com/us/stock/keenova-therapeutics-plc/additional-paid-in-capital https://stock.noler.com/us/stock/keenova-therapeutics-plc/advertising-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/keenova-therapeutics-plc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/amortization https://stock.noler.com/us/stock/keenova-therapeutics-plc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/aoci https://stock.noler.com/us/stock/keenova-therapeutics-plc/asset-impairment-charges https://stock.noler.com/us/stock/keenova-therapeutics-plc/asset-retirement-obligation https://stock.noler.com/us/stock/keenova-therapeutics-plc/asset-retirement-obligation-accretion-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/asset-retirement-obligation-cash-paid-to-settle https://stock.noler.com/us/stock/keenova-therapeutics-plc/asset-retirement-obligation-change https://stock.noler.com/us/stock/keenova-therapeutics-plc/asset-retirement-obligation-foreign-currency-translation https://stock.noler.com/us/stock/keenova-therapeutics-plc/asset-retirement-obligation-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/keenova-therapeutics-plc/asset-retirement-obligation-liabilities-incurred https://stock.noler.com/us/stock/keenova-therapeutics-plc/assets-fair-value-disclosure https://stock.noler.com/us/stock/keenova-therapeutics-plc/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/bankruptcy-claims-number-claims-filed https://stock.noler.com/us/stock/keenova-therapeutics-plc/basic-shares https://stock.noler.com/us/stock/keenova-therapeutics-plc/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/keenova-therapeutics-plc/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/keenova-therapeutics-plc/business-acquisition-pro-forma-income-loss-from-before-changes-in-accounting-and-extraordinary-items-net-of-tax-per-share-basic https://stock.noler.com/us/stock/keenova-therapeutics-plc/business-acquisition-pro-forma-income-loss-from-before-changes-in-accounting-and-extraordinary-items-net-of-tax-per-share-diluted https://stock.noler.com/us/stock/keenova-therapeutics-plc/business-acquisitions-pro-forma-income-loss-from-before-changes-in-accounting-and-extraordinary-items-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/keenova-therapeutics-plc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/keenova-therapeutics-plc/buyback-authorization https://stock.noler.com/us/stock/keenova-therapeutics-plc/buybacks-share-repurchases https://stock.noler.com/us/stock/keenova-therapeutics-plc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/buybacks-stock-repurchased-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/keenova-therapeutics-plc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-expenditures https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-lease-obligations-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/keenova-therapeutics-plc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/keenova-therapeutics-plc/capitalized-contract-cost-amortization https://stock.noler.com/us/stock/keenova-therapeutics-plc/capitalized-contract-cost-gross https://stock.noler.com/us/stock/keenova-therapeutics-plc/capitalized-contract-cost-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-and-equivalents https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-and-restricted-cash https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-and-restricted-cash-change https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-and-restricted-cash-change-disposal-group-including-discontinued-operations https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-dividends-paid-to-parent-company-by-consolidated-subsidiaries https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-flow-breakdown https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-flow-hedge-derivative-instrument-assets-at-fair-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-provided-by-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/keenova-therapeutics-plc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/keenova-therapeutics-plc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/keenova-therapeutics-plc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/keenova-therapeutics-plc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/keenova-therapeutics-plc/co-selected-measure-amt https://stock.noler.com/us/stock/keenova-therapeutics-plc/common-stock-other-value-outstanding https://stock.noler.com/us/stock/keenova-therapeutics-plc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/keenova-therapeutics-plc/common-stock-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/common-stock-value-outstanding https://stock.noler.com/us/stock/keenova-therapeutics-plc/comprehensive-income https://stock.noler.com/us/stock/keenova-therapeutics-plc/concept-patents-allegedly-infringed-number-tag-2 https://stock.noler.com/us/stock/keenova-therapeutics-plc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/keenova-therapeutics-plc/contract-liability https://stock.noler.com/us/stock/keenova-therapeutics-plc/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-change-in-estimate-of-transaction-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/contract-with-customer-liability-increase-decrease-for-contract-acquired-in-business-combination https://stock.noler.com/us/stock/keenova-therapeutics-plc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/cost-of-goods-sold https://stock.noler.com/us/stock/keenova-therapeutics-plc/cost-of-revenue https://stock.noler.com/us/stock/keenova-therapeutics-plc/cover-page-shares-outstanding https://stock.noler.com/us/stock/keenova-therapeutics-plc/current-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/current-liabilities https://stock.noler.com/us/stock/keenova-therapeutics-plc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/keenova-therapeutics-plc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-and-capital-lease-obligations https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-carrying-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-face-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-issued https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-longterm-and-shortterm-combined-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-maturing-in-year-five https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-maturing-in-year-four https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-maturing-in-year-three https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-maturing-in-year-two https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-unamortized-premium https://stock.noler.com/us/stock/keenova-therapeutics-plc/debt-unused-borrowing-capacity-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/debtor-reorganization-items-debtor-in-possession-facility-financing-costs https://stock.noler.com/us/stock/keenova-therapeutics-plc/debtor-reorganization-items-gain-loss-on-settlement-of-other-claims-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/debtor-reorganization-items-legal-and-advisory-professional-fees https://stock.noler.com/us/stock/keenova-therapeutics-plc/debtor-reorganization-items-provision-for-expected-allowed-claims https://stock.noler.com/us/stock/keenova-therapeutics-plc/debtor-reorganization-items-write-off-of-deferred-financing-costs-and-debt-discounts https://stock.noler.com/us/stock/keenova-therapeutics-plc/decrease-in-utb-is-reasonably-possible https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-compensation-liability-current-and-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-compensation-plan-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-finance-costs-current-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-finance-costs-gross https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-finance-costs-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-asset-interest-carryforward https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-gross https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-gross-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-compensation https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-postretirement-benefits https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-expense-from-stock-options-exercised https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-liabilities https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-liabilities-deferred-expense-capitalized-inventory-costs https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/keenova-therapeutics-plc/deferred-tax-liabilities-undistributed-foreign-earnings https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-benefit-plan-accumulated-benefit-obligation https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-benefit-plan-effect-of-one-percentage-point-decrease-on-accumulated-postretirement-benefit-obligation https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-benefit-plan-effect-of-one-percentage-point-decrease-on-service-and-interest-cost-components https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-benefit-plan-effect-of-one-percentage-point-increase-on-accumulated-postretirement-benefit-obligation https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-benefit-plan-effect-of-one-percentage-point-increase-on-service-and-interest-cost-components https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-accumulated-benefit-obligation https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-fair-value-of-plan-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-benefit-plan-recognized-net-gain-loss-due-to-settlements-and-curtailments https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/keenova-therapeutics-plc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/keenova-therapeutics-plc/depreciation https://stock.noler.com/us/stock/keenova-therapeutics-plc/depreciation-and-amortization https://stock.noler.com/us/stock/keenova-therapeutics-plc/depreciation-expense-on-reclassified-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/derivative-cap-interest-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/derivative-liabilities https://stock.noler.com/us/stock/keenova-therapeutics-plc/derivative-notional-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/diluted-shares https://stock.noler.com/us/stock/keenova-therapeutics-plc/dilutive-securities https://stock.noler.com/us/stock/keenova-therapeutics-plc/dilutive-shares https://stock.noler.com/us/stock/keenova-therapeutics-plc/discontinued-operation-income-loss-from-discontinued-operation-during-phase-out-period-before-income-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/discontinued-operation-tax-effect-of-discontinued-operation https://stock.noler.com/us/stock/keenova-therapeutics-plc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/disposal-group-including-discontinued-operation-cash https://stock.noler.com/us/stock/keenova-therapeutics-plc/disposal-group-including-discontinued-operation-consideration https://stock.noler.com/us/stock/keenova-therapeutics-plc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/keenova-therapeutics-plc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/keenova-therapeutics-plc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/keenova-therapeutics-plc/effective-tax-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/keenova-therapeutics-plc/employee-related-liabilities-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/eps https://stock.noler.com/us/stock/keenova-therapeutics-plc/eps-basic https://stock.noler.com/us/stock/keenova-therapeutics-plc/equity-method-investments https://stock.noler.com/us/stock/keenova-therapeutics-plc/equity-securities-fv-ni-current-and-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/equity-securities-fv-ni-realized-gain-loss https://stock.noler.com/us/stock/keenova-therapeutics-plc/equity-securities-fv-ni-unrealized-gain-loss https://stock.noler.com/us/stock/keenova-therapeutics-plc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/keenova-therapeutics-plc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/keenova-therapeutics-plc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-interest-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-principal-payments https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/keenova-therapeutics-plc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/keenova-therapeutics-plc/financing-cash-flow https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/keenova-therapeutics-plc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/keenova-therapeutics-plc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/foreign-earnings https://stock.noler.com/us/stock/keenova-therapeutics-plc/foreign-earnings-repatriated https://stock.noler.com/us/stock/keenova-therapeutics-plc/foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/foreign-pretax-income https://stock.noler.com/us/stock/keenova-therapeutics-plc/gain-loss-on-foreign-currency-fair-value-hedge-derivatives https://stock.noler.com/us/stock/keenova-therapeutics-plc/gain-loss-on-repurchase-of-debt-instrument https://stock.noler.com/us/stock/keenova-therapeutics-plc/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/keenova-therapeutics-plc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/keenova-therapeutics-plc/goodwill https://stock.noler.com/us/stock/keenova-therapeutics-plc/goodwill-acquired https://stock.noler.com/us/stock/keenova-therapeutics-plc/goodwill-change https://stock.noler.com/us/stock/keenova-therapeutics-plc/goodwill-gross https://stock.noler.com/us/stock/keenova-therapeutics-plc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/keenova-therapeutics-plc/goodwill-impairment-loss https://stock.noler.com/us/stock/keenova-therapeutics-plc/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/keenova-therapeutics-plc/goodwill-written-off-related-to-sale-of-business-unit https://stock.noler.com/us/stock/keenova-therapeutics-plc/gross-profit https://stock.noler.com/us/stock/keenova-therapeutics-plc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/keenova-therapeutics-plc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/keenova-therapeutics-plc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-loss-from https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-tax-examination-liability-refund-adjustment-from-settlement-with-taxing-authority https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-tax-expense-benefit-adjustment-of-deferred-tax-asset-liability https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-tax-expense-benefit-discontinued-operations-extraordinary-items https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-tax-holiday-aggregate-dollar-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-tax-paid-federal-after-refund-received https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-taxes-paid https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-taxes-paid-2 https://stock.noler.com/us/stock/keenova-therapeutics-plc/income-taxes-receivable https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-income-taxes-payable-net-of-income-taxes-receivable https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-inventories https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-notes-receivable-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-prepaid-taxes https://stock.noler.com/us/stock/keenova-therapeutics-plc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/keenova-therapeutics-plc/incremental-common-shares-attributable-to-nonvested-shares-with-forfeitable-dividends https://stock.noler.com/us/stock/keenova-therapeutics-plc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/keenova-therapeutics-plc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/keenova-therapeutics-plc/indefinitelived-intangible-assets-acquired https://stock.noler.com/us/stock/keenova-therapeutics-plc/insider-transactions-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/insider-transactions-stock-options https://stock.noler.com/us/stock/keenova-therapeutics-plc/insider-transactions-stock-units https://stock.noler.com/us/stock/keenova-therapeutics-plc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/keenova-therapeutics-plc/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/keenova-therapeutics-plc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/keenova-therapeutics-plc/interest-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/interest-expense-nonoperating https://stock.noler.com/us/stock/keenova-therapeutics-plc/interest-expense-operating https://stock.noler.com/us/stock/keenova-therapeutics-plc/interest-income-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/interest-paid-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/interest-payable-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/interest-rate-cash-flow-hedge-gain-loss-to-be-reclassified-during-next-12-months-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/inventory https://stock.noler.com/us/stock/keenova-therapeutics-plc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/keenova-therapeutics-plc/inventory-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/inventory-raw-materials-and-purchased-parts-net-of-reserves https://stock.noler.com/us/stock/keenova-therapeutics-plc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/keenova-therapeutics-plc/inventory-write-down https://stock.noler.com/us/stock/keenova-therapeutics-plc/investing-cash-flow https://stock.noler.com/us/stock/keenova-therapeutics-plc/lease-and-rental-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/lease-cost https://stock.noler.com/us/stock/keenova-therapeutics-plc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/level-3-liability-issues https://stock.noler.com/us/stock/keenova-therapeutics-plc/level-3-liability-settlements https://stock.noler.com/us/stock/keenova-therapeutics-plc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/keenova-therapeutics-plc/liabilities-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/keenova-therapeutics-plc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/liabilities-subject-to-compromise https://stock.noler.com/us/stock/keenova-therapeutics-plc/liabilities-subject-to-compromise-change https://stock.noler.com/us/stock/keenova-therapeutics-plc/line-of-credit-facility-unused-capacity-commitment-fee-percentage https://stock.noler.com/us/stock/keenova-therapeutics-plc/litigation-settlement-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-and-capital-lease-obligations-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-and-capital-lease-obligations-including-current-maturities https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-five https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-four https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-three https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-two https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-and-capital-lease-obligations-repayments-of-principal-in-next-twelve-months https://stock.noler.com/us/stock/keenova-therapeutics-plc/long-term-debt-fair-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/net-cash-from-discontinued-operations https://stock.noler.com/us/stock/keenova-therapeutics-plc/net-cash-from-financing-activities https://stock.noler.com/us/stock/keenova-therapeutics-plc/net-cash-from-investing-activities https://stock.noler.com/us/stock/keenova-therapeutics-plc/net-cash-from-operating-activities https://stock.noler.com/us/stock/keenova-therapeutics-plc/net-change-in-cash https://stock.noler.com/us/stock/keenova-therapeutics-plc/net-income https://stock.noler.com/us/stock/keenova-therapeutics-plc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/keenova-therapeutics-plc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-adoption-quantification https://stock.noler.com/us/stock/keenova-therapeutics-plc/non-hedging-derivatives-asset-at-fair-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/non-peo-neo-avg-comp-actually-paid-amt https://stock.noler.com/us/stock/keenova-therapeutics-plc/non-peo-neo-avg-total-comp-amt https://stock.noler.com/us/stock/keenova-therapeutics-plc/noncurrent-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/noninterest-income-other-operating-income https://stock.noler.com/us/stock/keenova-therapeutics-plc/nonoperating-gains-losses https://stock.noler.com/us/stock/keenova-therapeutics-plc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/number-of-operating-segments https://stock.noler.com/us/stock/keenova-therapeutics-plc/number-of-reportable-segments https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-amortization-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-for-net-prior-service-cost-credit-before-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-available-for-sale-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-before-reclassifications-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-before-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-cash-flow-hedge-gain-loss-after-reclassification-and-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-defined-benefit-plans-adjustment-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-derivatives-qualifying-as-hedges-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-derivatives-qualifying-as-hedges-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-net-investment-hedge-gain-loss-reclassification-before-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-net-of-tax-2 https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-pension-and-other-postretirement-benefit-plans-adjustment-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-pension-and-other-postretirement-benefit-plans-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-reclassification-adjustment-from-aoci-on-derivatives-before-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-reclassification-adjustment-from-aoci-on-derivatives-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-reclassification-adjustment-from-aoci-on-derivatives-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-reclassification-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-before-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-reclassification-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-for-net-gain-loss-before-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-reclassification-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-reclassification-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-unrealized-holding-gain-loss-on-securities-arising-before-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-cash-flow https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-income https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-cost https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-liability https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-liability-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/operating-loss-carryforwards https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-asset-impairment-charges https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-assets-fair-value-disclosure https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-current-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-current-liabilities https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-noncash-income-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-noncurrent-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-noncurrent-liabilities https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-nonoperating-income-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/other-tax-expense-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/paid-in-capital-income-tax-deficiency-from-share-based-compensation https://stock.noler.com/us/stock/keenova-therapeutics-plc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/keenova-therapeutics-plc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/keenova-therapeutics-plc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/keenova-therapeutics-plc/payment-for-contingent-consideration-liability-financing-activities https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-for-legal-settlements https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-for-repurchase-of-warrants https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-for-restructuring https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-of-distributions-to-affiliates https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-of-financing-costs https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/payments-to-acquire-interest-in-subsidiaries-and-affiliates https://stock.noler.com/us/stock/keenova-therapeutics-plc/peer-group-total-shareholder-rtn-amt https://stock.noler.com/us/stock/keenova-therapeutics-plc/pension-and-other-postretirement-defined-benefit-plans-liabilities-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/preferred-shares-facts https://stock.noler.com/us/stock/keenova-therapeutics-plc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/keenova-therapeutics-plc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/keenova-therapeutics-plc/preferred-stock-shares-issued https://stock.noler.com/us/stock/keenova-therapeutics-plc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/keenova-therapeutics-plc/preferred-stock-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/preferred-stock-value-outstanding https://stock.noler.com/us/stock/keenova-therapeutics-plc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/pretax-income https://stock.noler.com/us/stock/keenova-therapeutics-plc/pretax-income-domestic https://stock.noler.com/us/stock/keenova-therapeutics-plc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/keenova-therapeutics-plc/prior-period-reclassification-adjustment https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-divestiture-of-businesses-net-of-cash-divested https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-life-insurance-policies https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-sale-of-equity-securities-fv-ni https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-sale-of-restricted-investments https://stock.noler.com/us/stock/keenova-therapeutics-plc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/keenova-therapeutics-plc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/keenova-therapeutics-plc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/keenova-therapeutics-plc/property-plant-and-equipment-transfers-and-changes https://stock.noler.com/us/stock/keenova-therapeutics-plc/property-plant-equipment https://stock.noler.com/us/stock/keenova-therapeutics-plc/public-float https://stock.noler.com/us/stock/keenova-therapeutics-plc/purchase-obligations-balance-on-fifth-anniversary https://stock.noler.com/us/stock/keenova-therapeutics-plc/purchase-obligations-balance-on-first-anniversary https://stock.noler.com/us/stock/keenova-therapeutics-plc/purchase-obligations-balance-on-fourth-anniversary https://stock.noler.com/us/stock/keenova-therapeutics-plc/purchase-obligations-balance-on-second-anniversary https://stock.noler.com/us/stock/keenova-therapeutics-plc/purchase-obligations-balance-on-third-anniversary https://stock.noler.com/us/stock/keenova-therapeutics-plc/range-of-possible-loss-maximum https://stock.noler.com/us/stock/keenova-therapeutics-plc/range-of-possible-loss-minimum https://stock.noler.com/us/stock/keenova-therapeutics-plc/realized-investment-gains-losses https://stock.noler.com/us/stock/keenova-therapeutics-plc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/reclassification-from-aoci-current-period-before-tax-attributable-to-parent https://stock.noler.com/us/stock/keenova-therapeutics-plc/reorganization-items https://stock.noler.com/us/stock/keenova-therapeutics-plc/reorganization-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/reorganization-value-present-value-of-discounted-cash-flows-of-emerging-entity https://stock.noler.com/us/stock/keenova-therapeutics-plc/repayments-of-debt https://stock.noler.com/us/stock/keenova-therapeutics-plc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/keenova-therapeutics-plc/repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/keenova-therapeutics-plc/repayments-of-other-long-term-debt https://stock.noler.com/us/stock/keenova-therapeutics-plc/research-and-development https://stock.noler.com/us/stock/keenova-therapeutics-plc/restricted-cash https://stock.noler.com/us/stock/keenova-therapeutics-plc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/restricted-cash-and-investments-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/restricted-cash-and-investments-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/restricted-cash-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/restricted-cash-noncurrent https://stock.noler.com/us/stock/keenova-therapeutics-plc/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-and-related-cost-cost-incurred-to-date https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-and-related-cost-incurred-cost https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-charges https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-reserve https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-reserve-accelerated-depreciation https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-reserve-accrual-adjustment-1 https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-reserve-translation-adjustment https://stock.noler.com/us/stock/keenova-therapeutics-plc/restructuring-reserve-translation-and-other-adjustment https://stock.noler.com/us/stock/keenova-therapeutics-plc/retained-earnings https://stock.noler.com/us/stock/keenova-therapeutics-plc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/keenova-therapeutics-plc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/keenova-therapeutics-plc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/keenova-therapeutics-plc/royalty-revenue https://stock.noler.com/us/stock/keenova-therapeutics-plc/sales-revenue-goods-net https://stock.noler.com/us/stock/keenova-therapeutics-plc/secured-debt https://stock.noler.com/us/stock/keenova-therapeutics-plc/self-insurance-reserve https://stock.noler.com/us/stock/keenova-therapeutics-plc/sga-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/share-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/shareholders-equity https://stock.noler.com/us/stock/keenova-therapeutics-plc/shares-authorized https://stock.noler.com/us/stock/keenova-therapeutics-plc/shares-issued https://stock.noler.com/us/stock/keenova-therapeutics-plc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/keenova-therapeutics-plc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/keenova-therapeutics-plc/short-term-lease-cost https://stock.noler.com/us/stock/keenova-therapeutics-plc/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/keenova-therapeutics-plc/significant-change-in-utb-is-reasonably-possible-estimated-range-of-change-upper-bound https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-discount-from-market-price-purchase-date https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-options-other-share-increase-decrease-in-period-average-exercise-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-award-rsu-share-based-liabilities-paid https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-based-compensation https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-compensation-cash-flow-effect-cash-used-to-settle-awards https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-compensation-tax-benefit-from-exercise-of-stock-options https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-shares-issued-for-stock-awards https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-shares-issued-shares-treasury-stock-reissued https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-shares-issued-value-treasury-stock-reissued https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-exercisable-number https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-other-increases-decreases-in-period https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-outstanding-number https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/keenova-therapeutics-plc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/keenova-therapeutics-plc/sublease-income https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-nondeductible-expense-amortization https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-deductions-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-disposition-of-business https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-nondeductible-expense-amortization https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-repatriation-of-foreign-earnings https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-tax-contingencies-other https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/keenova-therapeutics-plc/tax-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/keenova-therapeutics-plc/taxes-payable-current https://stock.noler.com/us/stock/keenova-therapeutics-plc/total-assets https://stock.noler.com/us/stock/keenova-therapeutics-plc/total-contract-liability https://stock.noler.com/us/stock/keenova-therapeutics-plc/total-liabilities https://stock.noler.com/us/stock/keenova-therapeutics-plc/total-liabilities-and-equity https://stock.noler.com/us/stock/keenova-therapeutics-plc/total-shareholder-rtn-amt https://stock.noler.com/us/stock/keenova-therapeutics-plc/treasury-stock-common-shares https://stock.noler.com/us/stock/keenova-therapeutics-plc/treasury-stock-retired-cost-method-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/treasury-stock-shares https://stock.noler.com/us/stock/keenova-therapeutics-plc/treasury-stock-value https://stock.noler.com/us/stock/keenova-therapeutics-plc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/undistributed-earnings-allocated-to-participating-securities https://stock.noler.com/us/stock/keenova-therapeutics-plc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/keenova-therapeutics-plc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/keenova-therapeutics-plc/unrealized-gain-loss-on-interest-rate-cash-flow-hedges-pretax-accumulated-oci-loss https://stock.noler.com/us/stock/keenova-therapeutics-plc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/keenova-therapeutics-plc/unrecognized-deferred-tax-liability-foreign-earnings https://stock.noler.com/us/stock/keenova-therapeutics-plc/unrecognized-tax-benefits https://stock.noler.com/us/stock/keenova-therapeutics-plc/unsecured-debt https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-change https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-decrease-from-acquisition https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-decrease-from-settlements https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-interest-on-income-taxes-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/keenova-therapeutics-plc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/keenova-therapeutics-plc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/keenova-therapeutics-plc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/keenova-therapeutics-plc/valuation-allowances-and-reserves-charged-to-other-accounts https://stock.noler.com/us/stock/keenova-therapeutics-plc/variable-lease-cost https://stock.noler.com/us/stock/keenova-therapeutics-plc/write-off-of-deferred-debt-issuance-cost